Quarter Financials
Thermo Fisher Scientific Inc. (TMO)
$548.27
+4.99 (+0.92%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
Net Income | 2,215 | 1,658 | 1,902 | 1,828 | 2,337 | 2,498 | 1,933 | 1,156 |
Dividend Paid | -103 | -103 | -102 | -103 | -87 | -87 | -87 | -87 |
Retained Earnings | 37,528 | 35,431 | 33,876 | 32,076 | 30,350 | 28,116 | 25,705 | 23,860 |
---|
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
Capital Expenditure | -640 | -831 | -524 | -540 | -628 | -586 | -366 | -269 |
Net PPE | 8,448 | 8,333 | 7,049 | 6,560 | 6,133 | 5,912 | 5,180 | 4,887 |
---|
Year
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
2020 Q2
|
New Purchases | - | - | - | - | - | - | - | - |
Intangible and Goodwill | 25,700 | 25,782 | 26,041 | 26,823 | 26,904 | 26,909 | 41,924 | 41,721 |
---|